Fundraising FoxNXI Therapeutics
5 known investors
Find your way into NXI Therapeutics
Sign up to find every way you can get introduced to NXI Therapeutics
- Your email: who you already know at NXI Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the NXI Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Immunotherapies for T cell-mediated autoimmune conditions via modulation of coronin 1; spin-off from the University of Basel.
Founders & leadership
Investors · 5
BioMedPartnerslisted by BioMedPartnersBasel · $648K – $6.5M
How we know: BioMedPartners's portfolio page · Not right? Tell us
Kickfundlisted by KickfundBasel · $950K
How we know: funding news · baselaunch.ch · the VCSheet dataset · Not right? Tell us
Venture KickreportedSchlieren-Zürich
How we know: funding news · baselaunch.ch · Not right? Tell us
Also in the syndicate · 2
BaseLaunchJFG Life Sciences Foundationlead
Funding
SEC filings, press & company announcements- Undisclosed amountpre-seed financingJun 2024
JFG Life Sciences Foundation (lead), BaseLaunch, Kickfund, Venture Kick
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does NXI Therapeutics do?
- Immunotherapies for T cell-mediated autoimmune conditions via modulation of coronin 1; spin-off from the University of Basel.
- Who founded NXI Therapeutics?
- NXI Therapeutics was founded by Rajesh Jayachandran, MD PhD.
- Who are NXI Therapeutics's investors?
- NXI Therapeutics's investors include BioMedPartners, Kickfund, Venture Kick.